Losartan Related Compound B

CAS : 1006062-27-6

Ref. 3D-FL164204

Informations sur le produit

• Nom: Losartan Related Compound B
• Synonymes: [2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methyl Acetate, 2-Butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]-1H-iMidazole-5-Methanol 5-Acetate, O-Acetyl Losartan, [2-Butyl-4-chloro-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazol-5-yl]methyl acetate, (1-((2′-(2H-Tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methyl acetate, 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, 5-acetate, (1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methyl acetate

Description

Losartan Related Compound B is a nonpolar, synthetic organic compound that has the chemical formula CHClNO. It has been shown to inhibit nitrosamine formation in vitro and has a spectrum of activity against nitrosamines and other genotoxic impurities. Losartan Related Compound B is an innovative, analytical method for the detection of valsartan and its metabolites in pharmaceuticals. This substance fulfills pharmacological criteria as it inhibits angiotensin II-induced proliferation of vascular smooth muscle cells, vasoconstriction, and platelet aggregation.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 464.95 g/mol
• Formule: C₂₄H₂₅ClN₆O₂
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C24H25ClN6O2/c1-3-4-9-22-26-23(25)21(15-33-16(2)32)31(22)14-17-10-12-18(13-11-17)19-7-5-6-8-20(19)24-27-29-30-28-24/h5-8,10-13H,3-4,9,14-15H2,1-2H3,(H,27,28,29,30)
• Code InChI: InChIKey=HIUYRCVDCVFSBP-UHFFFAOYSA-N
• SMILES: CCCCc1nc(Cl)c(COC(C)=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1